Biotherapeutics Inc said cooperative finding interleukin-2 , anti-cancer drug , published today `` New England Journal Medicine '' .
Biotherapeutics , along Biological Therapy Institute National Cancer Institute , said publication focused reduction toxicity use constant infusion mode intravenous administration protocol .
Reuter & # 3 ; 